The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis.
about
Antithrombin III for critically ill patientsSepsis and disseminated intravascular coagulationAntithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis.Effect of Antiplatelet Therapy on Acute Respiratory Distress Syndrome and Mortality in Critically Ill Patients: A Meta-AnalysisInflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunctionEfficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trialsNew paradigms in sepsis: from prevention to protection of failing microcirculation.Heparin-binding protein is important for vascular leak in sepsisThe role of heparin in sepsis: much more than just an anticoagulant.Endothelial and Microcirculatory Function and Dysfunction in Sepsis.Delayed Surgical Debridement and Use of Semiocclusive Dressings for Salvage of Fingers After Purpura Fulminans.Comparison of the Effects of Subcutaneous Versus Continuous Infusion of Heparin on Key Inflammatory Parameters Following Sepsis.Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity-Weighted Cohort Study.Unfractionated heparin protects the protein C system against lipopolysaccharide-induced damage in vivo and in vitro.Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways.
P2860
Q24186159-ACD89057-8070-471E-AA0F-1D4423D95A92Q26751555-36B96D9A-5206-4D26-8889-41AB92E8A854Q34513234-6DDF9B4D-F522-4847-9580-861A5B783901Q36018451-C6CDDD2F-2F73-4689-91F4-2839D8977414Q36335932-731B0B01-A9A4-4CBA-BEC7-6DAFCAF52BF0Q36415327-01C6ED9C-6BBA-4D7F-BD8C-A211E6D2878BQ36903211-5859E2E1-3359-423F-827A-43243687EBCAQ37238202-CBA6118F-1706-4C82-8560-6C83F91A0934Q37309943-7878FCBB-22B1-46D4-B104-0B05F57AE353Q38612382-8D0563A9-DFC0-435C-8C7A-DCEC6E26491CQ38845321-4FAAA37A-B756-45B8-9573-8B027C52F42CQ40349603-BDBEDEAF-2473-4B52-B974-B80149D89489Q42750309-D178811A-4FB3-45B1-9C34-791E3ED874A2Q47114683-C3019D9A-D0B2-4419-B4F5-CACEC4FC8943Q47133536-FF151DBD-366A-4D0E-83D8-5DDE3C456287Q48371887-8A04AEB6-D13F-43AD-BE78-8C528CC0CB61
P2860
The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The efficacy and safety of hep ...... matic review and metaanalysis.
@ast
The efficacy and safety of hep ...... matic review and metaanalysis.
@en
type
label
The efficacy and safety of hep ...... matic review and metaanalysis.
@ast
The efficacy and safety of hep ...... matic review and metaanalysis.
@en
prefLabel
The efficacy and safety of hep ...... matic review and metaanalysis.
@ast
The efficacy and safety of hep ...... matic review and metaanalysis.
@en
P2093
P50
P1476
The efficacy and safety of hep ...... matic review and metaanalysis.
@en
P2093
Ahmed M Abou-Setta
Alexis F Turgeon
Alison E Fox-Robichaud
Anand Kumar
Canadian Critical Care Trials Group
Deborah J Cook
Donald S Houston
Emily Rimmer
Lauralyn McIntyre
Paul Hébert
P304
P356
10.1097/CCM.0000000000000763
P407
P577
2015-03-01T00:00:00Z